Compounds > 5,11-dimethyl-5h-indolo(2,3-b)quinoline
Page last updated: 2024-09-04

5,11-dimethyl-5h-indolo(2,3-b)quinoline and dimyristoylphosphatidylglycerol

5,11-dimethyl-5h-indolo(2,3-b)quinoline has been researched along with dimyristoylphosphatidylglycerol in 1 studies

Compound Research Comparison

Studies
(5,11-dimethyl-5h-indolo(2,3-b)quinoline)		Trials
(5,11-dimethyl-5h-indolo(2,3-b)quinoline)		Recent Studies (post-2010)
(5,11-dimethyl-5h-indolo(2,3-b)quinoline)		Studies
(dimyristoylphosphatidylglycerol)		Trials
(dimyristoylphosphatidylglycerol)		Recent Studies (post-2010) (dimyristoylphosphatidylglycerol)
11054481126

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Godlewska, J; Gubernator, J; Kaczmarek, Ł; Kociubińska, A; Kozubek, A; Opolski, A; Peczyńska-Czoch, W; Stasiuk, M1

Other Studies

1 other study(ies) available for 5,11-dimethyl-5h-indolo(2,3-b)quinoline and dimyristoylphosphatidylglycerol

ArticleYear
A derivative of 5-H-indolo[2,3-b]quinoline--a novel liposomally-formulated anticancer agent.
    Cellular & molecular biology letters, 2002, Volume: 7, Issue:2

    Topics: Antineoplastic Agents; Carbolines; Dimyristoylphosphatidylcholine; Drug Carriers; Humans; Liposomes; Phosphatidylglycerols; Topoisomerase II Inhibitors; Tumor Cells, Cultured

2002